STAT

STAT+: FDA pauses Regenxbio gene therapy trial again due to safety concerns

STAT+: FDA pauses Regenxbio gene therapy trial again due to safety concernsWorldPing

The FDA put a hold on a Regenxbio gene therapy trial again after new safety concerns emerged.

This is a short WorldPing brief. The full report was published by STAT.

Read the full report at STAT

Related news

Burnham accuses Russia of ‘outrageous threats’ against UK as he visits KyivWorldPing
The Guardian

Burnham accuses Russia of ‘outrageous threats’ against UK as he visits Kyiv

Moscow warns of increased tensions with Britain as Burnham offers Ukraine declassified details of missile components Europe live – latest updates Andy Burnham has accused the Kremlin of “outrageous threats” against the UK as Russia warned of an escal…

Brief by WorldPing · Original reporting by The Guardian